Histocompatibility testing for highly sensitized transplant candidates

Area of Science:

• Immunology
• Transplantation Science
• Clinical Chemistry

Background:

• Human leukocyte antigen (HLA) antibodies are frequently detected in patients awaiting renal transplantation.
• These antibodies pose significant challenges in finding compatible donors and are associated with adverse graft outcomes.
• Accurate detection of HLA antibodies is vital for pretransplantation risk assessment and posttransplantation rejection diagnosis.

Purpose of the Study:

• To review the significance of HLA antibody detection in renal transplantation.
• To discuss the role of HLA antibodies in donor compatibility and graft prognosis.
• To provide an overview of current assays for HLA antibody detection.

Main Methods:

• Review of existing literature on HLA antibody detection methods.
• Description of various immunological assays used for antibody screening.
• Analysis of the clinical utility of HLA antibody testing.

Main Results:

• HLA antibodies are a major barrier to successful renal transplantation.
• Antibody detection aids in identifying compatible donors and assessing rejection risk.
• Various assays, including cytotoxicity, flow cytometry, and solid-phase methods, are available for HLA antibody detection.

Conclusions:

• Effective detection and management of HLA antibodies are critical for improving renal transplant success rates.
• Understanding HLA antibody profiles enhances donor selection and patient management.
• The reviewed assays provide essential tools for clinical decision-making in transplantation.